| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |